Foghorn Therapeutics Files 8-K
Ticker: FHTX · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1822462
| Field | Detail |
|---|---|
| Company | Foghorn Therapeutics Inc. (FHTX) |
| Form Type | 8-K |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Foghorn Therapeutics filed an 8-K on 4/28/25 covering Reg FD, other events, and financials.
AI Summary
Foghorn Therapeutics Inc. filed an 8-K on April 28, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company is incorporated in Delaware and headquartered in Cambridge, MA.
Why It Matters
This 8-K filing provides updates on Foghorn Therapeutics' corporate activities and financial reporting, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting various corporate events and financial statements, not indicating any immediate significant risks.
Key Numbers
- 0001822462 — Central Index Key (Unique identifier for Foghorn Therapeutics Inc.)
- 001-39634 — SEC File Number (SEC filing identifier for Foghorn Therapeutics Inc.)
Key Players & Entities
- Foghorn Therapeutics Inc. (company) — Registrant
- 0001822462 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 001-39634 (company) — SEC File Number
- Cambridge, MA (company) — Principal Executive Offices Location
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a current report for Foghorn Therapeutics Inc. and covers Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on April 28, 2025.
Where is Foghorn Therapeutics Inc. headquartered?
Foghorn Therapeutics Inc.'s principal executive offices are located at 500 Technology Square, Suite 700, Cambridge, MA 02139.
What is Foghorn Therapeutics Inc.'s Standard Industrial Classification code?
Foghorn Therapeutics Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Foghorn Therapeutics Inc.?
The SEC file number for Foghorn Therapeutics Inc. is 001-39634.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Foghorn Therapeutics Inc. (FHTX).